Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Kaposi 1Sarcoma 1AIDS-related Kaposi sarcoma 1

Interventions

liposomal doxorubicin 2Thalidomide 2Semaxinib 2Paclitaxel 2Filgrastim 2Etoposide 2Docetaxel 2valspodar 1halofuginone 1etoposide phosphate 1entinostat 1Valproic Acid 1Sunitinib 1Sirolimus 1Saquinavir 1Ritonavir 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Nelfinavir 1N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3- dimethyl-L-Valinamide 1Lenalidomide 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Imatinib Mesylate 1Ifosfamide 1Histological Techniques 1Gemcitabine 1Daunorubicin 1Cidofovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × AIDS-related Kaposi sarcoma × Saquinavir × Clear all
NCT00003008 2023-06-15

Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma

Eastern Cooperative Oncology Group

Phase 2 Completed
33 enrolled
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡